The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
出版年份 2018 全文链接
标题
The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-09-25
DOI
10.3389/fimmu.2018.02159
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CXCL5 Facilitates Melanoma Cell–Neutrophil Interaction and Lymph Node Metastasis
- (2018) Ana Soler-Cardona et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models
- (2018) Nicole Salazar et al. MOLECULAR THERAPY
- CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
- (2018) Yang Zhang et al. OncoTargets and Therapy
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
- (2018) Mieke Metzemaekers et al. Frontiers in Immunology
- Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
- (2018) Manja Idorn et al. OncoImmunology
- Targeting both tumour-associated CXCR2+neutrophils and CCR2+macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
- (2017) Timothy M Nywening et al. GUT
- The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression
- (2017) Ya Cao et al. IMMUNOLOGICAL INVESTIGATIONS
- Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages
- (2017) Francesca Bellora et al. JOURNAL OF IMMUNOLOGY
- A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer
- (2017) Ravi Salgia et al. LUNG CANCER
- A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
- (2017) Z Xiang et al. ONCOGENE
- Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer
- (2017) Jingkun Zhao et al. Oncotarget
- Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
- (2017) Larissa Kistner et al. Oncotarget
- CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients
- (2017) C Windmüller et al. Oncogenesis
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- (2016) Holger Bronger et al. BRITISH JOURNAL OF CANCER
- Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
- (2016) C. Alfaro et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
- (2016) Yana G. Najjar et al. CLINICAL CANCER RESEARCH
- CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
- (2016) Chang Xian Li et al. JOURNAL OF HEPATOLOGY
- Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+T Cell Migration into Tumors
- (2016) Zinal S. Chheda et al. JOURNAL OF IMMUNOLOGY
- Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
- (2016) B. Behnam Azad et al. JOURNAL OF NUCLEAR MEDICINE
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
- (2016) S Lefort et al. ONCOGENE
- CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
- (2016) T. Chao et al. Cancer Immunology Research
- The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
- (2016) Shuo Zhang et al. PLoS One
- CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma
- (2015) Yusuke Sato et al. ANNALS OF SURGICAL ONCOLOGY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints
- (2015) M. E. Mikucki et al. Nature Communications
- CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity
- (2015) Guiquan Zhu et al. Oncotarget
- STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
- (2015) C. Yue et al. Cancer Immunology Research
- Chemokine Receptor Expression on Normal Blood CD56+NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population
- (2015) Margarida Lima et al. Journal of Immunology Research
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment
- (2015) Kar Wai Tan et al. OncoImmunology
- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
- (2014) Zhigang Zhang et al. BMC CANCER
- CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
- (2014) Erik Wennerberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
- (2014) Arnoud J. Templeton et al. JNCI-Journal of the National Cancer Institute
- Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
- (2014) Talib Hassan Ali et al. Nature Communications
- The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases
- (2014) Lianyu Chen et al. Scientific Reports
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non–Small Cell Lung Cancer Cells
- (2013) Young H. Choi et al. MOLECULAR CANCER RESEARCH
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis
- (2013) Jingxun Wu et al. TUMOR BIOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
- (2012) P. Saintigny et al. CANCER RESEARCH
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow
- (2011) G. Sciume et al. BLOOD
- Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
- (2011) K. Mayol et al. BLOOD
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
- (2011) N. Halama et al. CLINICAL CANCER RESEARCH
- Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
- (2011) Benjamin Toh et al. PLOS BIOLOGY
- CXCL12-CXCR4 chemokine signaling is essential for NK-cell development in adult mice
- (2010) M. Noda et al. BLOOD
- CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells
- (2010) S Amatschek et al. BRITISH JOURNAL OF CANCER
- Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses
- (2010) W. Peng et al. CLINICAL CANCER RESEARCH
- CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes
- (2010) R. D. Berahovich et al. JOURNAL OF IMMUNOLOGY
- Foxp3+ IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
- (2010) Shaobo Yang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis
- (2010) Fabio Morandi et al. PLoS One
- Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
- (2009) B Cambien et al. BRITISH JOURNAL OF CANCER
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
- (2009) Emmanuelle Pradelli et al. INTERNATIONAL JOURNAL OF CANCER
- CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets
- (2008) G. Bernardini et al. BLOOD
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro
- (2008) Ji-Kun Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Chemokine Receptor CXCR3 is an Independent Prognostic Factor in Patients With Localized Clear Cell Renal Cell Carcinoma
- (2007) Tobias Klatte et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation